These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12406926)

  • 1. Global vaccination meets global terror.
    CMAJ; 2002 Oct; 167(8):837, 839. PubMed ID: 12406926
    [No Abstract]   [Full Text] [Related]  

  • 2. The costs of scaling up vaccination in the world's poorest countries.
    Bishai D; McQuestion M; Chaudhry R; Wigton A
    Health Aff (Millwood); 2006; 25(2):348-56. PubMed ID: 16522576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial challenges of immunization: a look at GAVI.
    Kaddar M; Lydon P; Levine R
    Bull World Health Organ; 2004 Sep; 82(9):697-702. PubMed ID: 15628208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First countries to be recipients of GAVI funds.
    Maurice J
    Bull World Health Organ; 2000; 78(12):1477-8. PubMed ID: 11196504
    [No Abstract]   [Full Text] [Related]  

  • 6. Global perspectives on vaccine financing.
    Berman S; Giffin RB
    Expert Rev Vaccines; 2004 Oct; 3(5):557-62. PubMed ID: 15485335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health costs & financing and the work of WHO.
    Mach EP
    World Health Stat Q; 1984; 37(4):339-50. PubMed ID: 6523902
    [No Abstract]   [Full Text] [Related]  

  • 8. Rotavirus vaccines: targeting the developing world.
    Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
    J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global progress toward universal childhood hepatitis B vaccination, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(36):868-70. PubMed ID: 12970620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
    Goldie SJ; O'Shea M; Diaz M; Kim SY
    Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. World health and bioterrorism.
    Vincent J
    Clin Pharmacol Ther; 2009 Jun; 85(6):561-5. PubMed ID: 19451904
    [No Abstract]   [Full Text] [Related]  

  • 12. Global health. The new world of global health.
    Cohen J
    Science; 2006 Jan; 311(5758):162-7. PubMed ID: 16410496
    [No Abstract]   [Full Text] [Related]  

  • 13. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?
    Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S
    Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GAVI and the Vaccine Fund--a boon for immunization in the developing world.
    Balaji KA
    Indian J Public Health; 2004; 48(2):45-8. PubMed ID: 15709583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global efforts to eradicate polio.
    Krym VF; MacDonald RD
    CMAJ; 2004 Jan; 170(2):189-90. PubMed ID: 14734429
    [No Abstract]   [Full Text] [Related]  

  • 16. Economics of polio vaccination in the post-eradication era: should OPV-using countries adopt IPV?
    Khan MM
    Vaccine; 2008 Apr; 26(16):2034-40. PubMed ID: 18339460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The global vaccination gap.
    Mahmoud A
    Science; 2004 Jul; 305(5681):147. PubMed ID: 15247440
    [No Abstract]   [Full Text] [Related]  

  • 18. Polio endgame. Polio: The final assault?
    Roberts L
    Science; 2004 Mar; 303(5666):1960-8. PubMed ID: 15044779
    [No Abstract]   [Full Text] [Related]  

  • 19. Polio eradication: 7 countries and US$ 210 million to go.
    Fleck F
    Bull World Health Organ; 2003; 81(9):696-7. PubMed ID: 14710517
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost analysis of post-polio certification immunization policies.
    Sangrujee N; Cáceres VM; Cochi SL
    Bull World Health Organ; 2004 Jan; 82(1):9-15. PubMed ID: 15106295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.